{"name":"Cardiol Therapeutics Inc.","slug":"cardiol-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CardiolRx","genericName":"CardiolRx","slug":"cardiolrx","indication":"Acute myocardial infarction with reduced ejection fraction","status":"phase_3"}]}],"pipeline":[{"name":"CardiolRx","genericName":"CardiolRx","slug":"cardiolrx","phase":"phase_3","mechanism":"CardiolRx is a cardiac-regenerative therapy designed to repair and restore heart function following myocardial injury.","indications":["Acute myocardial infarction with reduced ejection fraction","Heart failure with reduced ejection fraction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPSW9Ba3FWM2xMMnVKMzVoV1pla2ZGX01obkd3Tmc2eFhKTHNLVmR1VkRrcnFnOEpRSnJwdW1DVmxfV0w2N0E2c2xxTV9uTWdTa0N6YzNhTlN4dEFVQ2ZBRWJ4ejhGMDExcmdyWkxRWUNsQXM3T1NDellYN0Z3endxUnh3NkVaNExaRUpPLVdTOUNBMVoxbUI1YkQ5d3o4SmpRVkZ1RUdWVTBNVVg2YVl5TnRDN296T3BxcFU4cHdMa2FBUEdja24ySGJfSW5mVzl6S3JNWnJDZDlfYzA2RV90RnZYVGtVcUlnbjFNd2pmdjlFV1JaTUlJS1dneXd5dkR1VU5VWGlpdVJ2RHpEVlZ0d1FTaWhQQ21qbWVkOTNR?oc=5","date":"2026-04-08","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNUmNOOHlwRlNTbUVHYmJxWWxSVnQxWVVqcWc4SFhjSjJ1UUJaT0dNcG5nNmpBVkcyMjA3X2FBbEh2RjR5RU84V0w5YXBCalYyaUtyRWpZU2RfNkZMcjJWQThCRWVXRUxSQkwzbnBKWlJtSkttYW9XVnNHTDRLVlBzSFlXVXZHMC04U0ZYdk85RDUwRDhBWDhKTEViOGVvdExUY3N6dzR3SGdERmliWGlPR01uQlVFSXhQeF9EZHAzc3VRelpjeUl3Q1FQV19ZdGZ6MTd5Mg?oc=5","date":"2026-04-01","type":"earnings","source":"MarketBeat","summary":"Cardiol Therapeutics (NASDAQ:CRDL) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat","headline":"Cardiol Therapeutics (NASDAQ:CRDL) Posts Earnings Results, Beats Expectations By $0.04 EPS","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPMjlDNEFWcXo2RUVRdkRZMVVtOVhyQ1FZUkhaa3NfZ3RpVnlUSlNEejlSZmk2OWdXU2tfQm02STROQWdyLUNJMmNwOUhQQkJDVVQxMUNib1didFExVklkNjFaNHlXOTJUVzdSNkUtUk5hT2FfNUVUTjdlYVdMZTk2UXdWNkFsZGNMbHd4Z01hM0NaOWh2LVVvVWpQQ1FOUkV1QlItSUlydlB3NHhGOFZERnpEWHVFVjcyRjlpdw?oc=5","date":"2026-04-01","type":"trial","source":"Stock Titan","summary":"Cardiol Therapeutics (NASDAQ: CRDL) advances 2025 cardiac trials and funding - Stock Titan","headline":"Cardiol Therapeutics (NASDAQ: CRDL) advances 2025 cardiac trials and funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW1hcHZDMzN4dEU1TmNEcFJ0cnZsMVo3eUJONmZxMWoyM1BsWXlzUEdDRFQ1RjktMy0xRVdXcWJKWXJmSzE3RmgtYnhSaGhNYVRkWC10QVZLOU9WMVo5ekxHZUlBUkIydlRwSndKOVZVbUhTSnI0RzMxR1pucldmX1BvbnlHdjV0NXVTYnJnU0thdGNHMUJZ?oc=5","date":"2026-01-12","type":"pipeline","source":"Yahoo Finance","summary":"Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance","headline":"Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQd2JTakl5dzA3czNfYVctbUJUTDMwMzBDY0c2eVc3T1NMczBfaFd1eFVDMEc2R21CdENmSEZPdGlMdFhreTBOM3pEQktCNW5hTko5bzZZQXNqdTNzZzhwMFF6NEY2dFlXakJSYmhkVld4TkQ4SzN5U0U2dDRIRm40VlVweVlZWnpRUFE2eGRlMzJ5SGo5QlVyYkw4QnE4MWo5bm1oWTU0bmVpcnZWdXhkbG1pNFYzLWhfZ3VwekRBVmd6djJhSUdDRWQ1OWhVMFVVbkE?oc=5","date":"2025-10-21","type":"earnings","source":"TMX Newsfile","summary":"Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 - TMX Newsfile","headline":"Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNOXdtUTFjMDdzc09wSXd0VVBWZWljRks0a0tpMGZWZi1EbV9rV3VERVdOR3RuZHFPY0E1WGpRbmRuNWc0ZlAwTERzLUExOGt6ZnI5MFN2YzdSbWdGUmxUdGlZTnoyTnlGcmFiVXhIalk1NHFQY09wZi05b0NoM2ZESFhwTmlJQ1RuajFMQjExYw?oc=5","date":"2025-10-15","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics an","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNWXdtbFZuR0VFeHVWVUNXSFRUX0RNNEstWXZVS2tOcl90ZmpSVHh2eVpQSDV2TFNncnpBWWxPQlpsb0wyLUZXeVdTVGdIcVdxTnFqQzdHejJHTXdPYXpKUS0tRE14RkRyalAtVndJWklwV05qLXBhZk5jSlYxTDNqV1ZBbFdFWVNuSGY4cnR3NktQaTliUVZlTDZtejNUMFBXRFFoOVF6UlNoQldGdlA1WXFrS1R1TkFQRjZnM3hiR0tMUlVkUzloQQ?oc=5","date":"2025-08-11","type":"pipeline","source":"Streetwise Reports","summary":"Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada - Streetwise Reports","headline":"Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOeThSazJHTE9Jam03S1MzNHctV3dkVmRDY3dqSFlqWUlGS3c4dWNNaVdFbS10S0RTZTNDTjFOVHpVSHluZjVfVHFFZWszVC1VWF8tQ1lWb3BXakhiWXd2M3llU2JwQkNrRFVIQU1vZFFDZVlYWXB3eXNLVWlCRFl1cmc4VXVSZGxa?oc=5","date":"2025-08-07","type":"trial","source":"Clinical Trials Arena","summary":"Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure - Clinical Trials Arena","headline":"Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZnljV0FtV1BPUThTNlJ5dEw3RDdPQWl1bE5WV3RjRG9wR1JZWEprdEFSTlc1RVg4S3huZE9ybFVaRXhJNFlXZWwxQTkxcTdKanpUbzhiU05OM1A0THU0YXRZbkRnWmc1cUlmREtYYjhWckJONnZyc0VSV01rTldUaUNmMlF3ckNWVFdtRkhsNjVQQm1TaDhtWlFoOW5jcWVPanRoYng4ZjkySmgybTRiMGpLcGZzblI1MWtIQUxrYjlPUU1jVmdQcVBEb19aSmxEcXAtNjd0RDY?oc=5","date":"2025-08-06","type":"trial","source":"Investing News Network","summary":"Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Investing News Network","headline":"Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNZ1pLaGlMcDJLUVR4cVdiS0xSVTQ0R19MbEFSS2tTcG5KQ0pfbkctNUwzcHVfaWtFZnVLMFlFNERJR1lUSk4xN0VjbWZsY19KektvMEUxbXVJNHQ2N1ctZk1EMzA5bDdNZklBOXNwT0FiRnByeHpfWjFSUTB5TTBwRWpjVGNSM3kxb0NIYzh5ekJ4Y2RjZmVBbndjVURueWZkYjZrN3JwdkV1bjYwb2JKamZPX0pmMUtlNzYwUnZn?oc=5","date":"2025-02-19","type":"pipeline","source":"Seeking Alpha","summary":"Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL) - Seeking Alpha","headline":"Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNR2U5TEc0eUlodWJsREpmUXliSTlWZFZCekQtMDhTM3FVZ2pnOENoYjBvM2VoYlFsVk1CLVM5YWRfRlkwdU01S1d1MEtOa0JaOTN1Skk3b2V2SEJ3YWpGN1puWURUQ3hNeV9uaEN5QmlUYnBpbEFsRU1WWjNvaVR4QUplR1NnUUptdEd4UG5xVVNLWUZfeXdlOVRVUXIwckI1ZDJ2a1RzQnN5M1Z1YzBwYWZiWTI?oc=5","date":"2024-08-22","type":"pipeline","source":"Seeking Alpha","summary":"Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease (NASDAQ:CRDL) - Seeking Alpha","headline":"Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease (NASDAQ:CRDL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1PeEhwY1lnZm5sMExLc3FwUkNhWWV2ellIZy1Rcm5tYjdGc1ZUQXRmWVFud29QTnN4WkVvYWJMX0hETkgyZ3B6OXBHNGw2YzRMTEpTMDVoVWhndV81M0FicGVtUnZFMUdYSTJyUHl4a0U?oc=5","date":"2023-04-13","type":"pipeline","source":"Investing News Network","summary":"Cardiol Therapeutics Stock Price, News, Quote & History - Investing News Network","headline":"Cardiol Therapeutics Stock Price, News, Quote & History","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}